Clinical Trial

Pectoral Nerve Block and Serratus Posterior Superior Intercostal Plane Block in Breast Cancer Surgery

Completed
View on ClinicalTrials.gov →
Summary
This randomized clinical trial aims to evaluate and compare the analgesic efficacy of the Pectoral Nerve Block (PECS II) and the Serratus Posterior Superior Intercostal Plane (SPSIP) Block in patients undergoing breast cancer surgery. The primary outcome is total opioid consumption in the first 24 hours. Secondary outcomes include pain scores (VAS), block performance time, number of needle passes, postoperative recovery quality (QoR-15), time to first analgesic request, and complications (hematoma, pneumothorax, local anesthetic toxicity, vascular puncture, infection).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-05-23; most recent amendment 2026-01-27.
Status change: Recruiting → Completed 2026-01-27
Status change: Not Yet Recruiting → Recruiting 2025-06-20
Trial Details
NCT Number NCT07001657
Lead Sponsor Antalya Training and Research Hospital
Conditions Nerve Block
Enrollment 118 participants
Start Date 2025-05-25
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-01-27 (estimated)
Updated on ClinicalTrials.gov 2026-01-28